May 31, 2025 05:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Operation Sindoor is not yet over, it's just a pause: Rajnath Singh | Army reduced terrorist hideouts to ruins: PM Modi on Operation Sindoor in Bihar | Prosperity came to Jammu and Kashmir after Article 370 abrogation: Salman Khurshid hails Modi govt's historic step | 'Disappointed': Shashi Tharoor on Colombia's condolence message for Pak deaths in Operation Sindoor | Nine tourists go missing after bus falls into swollen Teesta river in Sikkim | US Judge extends order blocking Trump ban on foreign students' enrolment in Harvard | India rejects Team Trump's latest claim on tariffs' role behind ceasefire with Pakistan | Operation Sindoor is not over yet: PM Modi's announcement from Bengal | 'Why aren't you giving sindoor to your wife first?': Mamata slams Modi on Operation Sindoor | Murshidabad and Malda communal violence reflect TMC govt's cruelty: Modi in Bengal
WHO | Covovax approval
Image credit: Pixabay

WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'

| @indiablooms | Dec 18, 2021, at 03:34 am

Geneva/IBNS: The World Health Organization (WHO) on Friday announced that  it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.

"Today, the World Health Organization issued and emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus," the WHO said in a statement.

The vaccine, named CovovaxTM, is produced by the Serum Institute of India (SII) under license from Novavax and is part of the COVAX facility portfolio.

The vaccine approval is "a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries."

WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.

“Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products.

"This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10% of their populations, while 98 countries have not reached 40%,” she said.

CovovaxTM was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.

The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19, that the benefit of the vaccine far outweighs any risks, and that the vaccine can be used globally, the WHO statement asserted.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu